TIGR-Tas


TIGR-Tas is a family of RNA-guided DNA-targeting systems discovered in prokaryotes and their viruses. These systems utilize a dual-spacer targeting mechanism, compared to the single spacer required by CRISPR-Cas9-mediated gene targeting.

Discovery

TIGR-Tas systems were reported in February 2025 by researchers at the Broad Institute of MIT and Harvard and MIT's McGovern Institute for Brain Research.
TIGR-Tas systems were discovered through computational mining approaches that began with structural analysis of the RNA-binding domain of SpCas9. Through iterative structural and sequence homology-based searches, protein were discovered that contain Nop domains—hallmarks of eukaryotic box C/D snoRNA ribonucleoproteins —associated with distinctive tandem interspaced guide RNA arrays.
The discovery process employed advanced computational methods, including protein large language models, to cluster related proteins based on their likely evolutionary relationships. This approach identified more than 20,000 different Tas proteins, predominantly from bacteriophages and parasitic bacteria.

System components

TIGR arrays

TIGR arrays consist of repetitive sequences organized into dual-repeat units or stem-loop structures. Each unit contains:Edge repeats and loop repeats Spacer A and Spacer B
  • Conserved box C and box D motifs similar to those found in snoRNAs

Tas proteins

TIGR-associated proteins are classified into three main types:TasA : Contains only the Nop domainTasH : Nop domain fused with an HNH nuclease domainTasR : Nop domain fused with a RuvC nuclease domain

Mechanism of action

RNA processing

TIGR arrays are transcribed and processed into 36-nucleotide guide RNAs called tigRNAs. Processing occurs at precise sites within edge repeats and requires the presence of Tas proteins, though the proteins themselves do not directly catalyze the cleavage.

DNA targeting

Unlike CRISPR systems that use a single guide RNA to target one DNA strand, TIGR systems employ a tandem-spacer targeting mechanism:
  • Spacer A pairs with one DNA strand
  • Spacer B pairs with the complementary DNA strand
  • Both spacers must be correctly paired for efficient cleavage
  • No protospacer-adjacent motif is required

Cleavage pattern

TasR nucleases create double-strand breaks with 8-nucleotide 3' overhangs, cleaving 3' to the nucleotide complementary to the 5th base of each spacer.

Structural features

Cryo-electron microscopy studies revealed that TasR forms a C2-symmetric dimer that binds target DNA and tigRNA. The structure shows:
  • Dramatic 180° DNA bending upon complex formation
  • Nop domains that recognize box C/D motifs in tigRNAs
  • RuvC domains positioned for coordinated cleavage of both DNA strands

Distribution and diversity

TIGR systems are found primarily in:
Two main architectural variants exist:
  1. Dual-repeat arrays: Traditional TIGR organization
  2. Stem-loop arrays: Alternative organization lacking separating repeats

Evolutionary relationships

TIGR systems show evolutionary connections to:IS110 transposases: Share structural domains and RNA-binding mechanismsBox C/D snoRNPs: Common Nop domain architecture and box C/D motifs
These relationships suggest TIGR systems may represent an ancestral form of RNA-guided systems.

Applications and potential

Genome editing

TIGR-TasR systems can be successfully adapted for:
  • Programmable DNA cleavage in human cells
  • Genome editing with unique targeting properties

Advantages over CRISPR

TIGR-Tas systems offer several potential advantages over CRISPR technology:No PAM requirement: Can theoretically target any genomic siteCompact size: Tas proteins are approximately one-quarter the size of Cas9, potentially facilitating cellular delivery for therapeutic applicationsDual-guide system: May enhance specificity by requiring correct recognition of both DNA strandsModularity: Distinct functional domains that could be engineered for various applications

Therapeutic potential

The small size and modularity of TIGR-Tas systems make them promising candidates for therapeutic gene editing applications, potentially overcoming delivery challenges associated with larger CRISPR proteins.

Biological functions

While the exact biological roles remain unclear, proposed functions include: